Elanco Animal Health Long Term Debt 2016-2026 | ELAN
Elanco Animal Health long term debt from 2016 to 2026. Long term debt can be defined as the sum of all long term debt fields.
- Elanco Animal Health long term debt for the quarter ending June 30, 2026 was $3.845B, a 7.3% decline year-over-year.
- Elanco Animal Health long term debt for 2025 was $3.943B, a 7.81% decline from 2024.
- Elanco Animal Health long term debt for 2024 was $4.277B, a 25.44% decline from 2023.
- Elanco Animal Health long term debt for 2023 was $5.736B, a 5.29% increase from 2022.
|
Elanco Animal Health Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2025 | $3,943 |
| 2024 | $4,277 |
| 2023 | $5,736 |
| 2022 | $5,448 |
| 2021 | $6,025 |
| 2020 | $5,572 |
| 2019 | $2,331 |
| 2018 | $2,443 |
|
Elanco Animal Health Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2026-06-30 | $3,845 |
| 2026-03-31 | $3,918 |
| 2025-12-31 | $3,943 |
| 2025-09-30 | $3,962 |
| 2025-06-30 | $4,148 |
| 2025-03-31 | $4,351 |
| 2024-12-31 | $4,277 |
| 2024-09-30 | $4,313 |
| 2024-06-30 | $5,463 |
| 2024-03-31 | $5,727 |
| 2023-12-31 | $5,736 |
| 2023-09-30 | $5,870 |
| 2023-06-30 | $6,023 |
| 2023-03-31 | $5,639 |
| 2022-12-31 | $5,448 |
| 2022-09-30 | $5,507 |
| 2022-06-30 | $6,007 |
| 2022-03-31 | $6,073 |
| 2021-12-31 | $6,025 |
| 2021-09-30 | $6,273 |
| 2021-06-30 | $5,542 |
| 2021-03-31 | $5,556 |
| 2020-12-31 | $5,572 |
| 2020-09-30 | $5,587 |
| 2020-06-30 | $2,030 |
| 2020-03-31 | $2,036 |
| 2019-12-31 | $2,331 |
| 2019-09-30 | $2,336 |
| 2019-06-30 | $2,382 |
| 2019-03-31 | $2,437 |
| 2018-12-31 | $2,443 |
| 2018-09-30 | $2,479 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $11.491B | $4.715B |
| Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.581B | 13.26 |
| Quest Diagnostics (DGX) | United States | $27.271B | 23.22 |
| DaVita (DVA) | United States | $12.179B | 14.91 |
| Encompass Health (EHC) | United States | $12.036B | 20.89 |
| Chemed (CHE) | United States | $6.620B | 23.60 |
| RadNet (RDNT) | United States | $6.069B | 175.27 |
| LifeStance Health (LFST) | United States | $4.991B | 100.46 |
| Option Care Health (OPCH) | United States | $3.523B | 14.89 |
| Aveanna Healthcare Holdings (AVAH) | United States | $3.123B | 21.68 |
| Addus HomeCare (ADUS) | United States | $2.164B | 19.57 |
| Astrana Health (ASTH) | United States | $2.138B | 22.69 |
| Pennant (PNTG) | United States | $1.396B | 36.34 |
| U.S Physical Therapy (USPH) | United States | $1.220B | 32.19 |
| Daxor (DXR) | United States | $0.065B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.024B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |